Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 230 publications
Adiposity-Associated Monocyte Costimulatory Programming in Rheumatoid Arthritis Identified by Single-Cell Transcriptomics.
Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026
"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 08, 2026
Comparative Performance of LFA-REAL, SLEDAI, and BILAG for Detecting Clinically Meaningful Changes in Lupus Activity.
Journal: Arthritis care & research
Published: November 13, 2025
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.
Journal: The New England journal of medicine
Published: October 15, 2025
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: October 10, 2025
Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.
Journal: Journal of clinical epidemiology
Published: June 20, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 22, 2025
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Journal: Annals of the rheumatic diseases
Published: May 06, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequences.
Journal: Science (New York, N.Y.)
Published: February 20, 2025
Last Updated: 09/26/2026